MARKET

NRXPW

NRXPW

Nrx Pharmaceuticals Inc
NASDAQ
0.0316
0.00
0.00%
Opening 09:30 03/05 EST
OPEN
--
PREV CLOSE
0.0316
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.1751
52 WEEK LOW
0.0293
MARKET CAP
--
P/E (TTM)
-0.0136
1D
5D
1M
3M
1Y
5Y
1D
NRx Pharmaceuticals Names Prof. Joshua Brown Chief Medical Innovation Officer
Reuters · 3d ago
Weekly Report: what happened at NRXPW last week (0223-0227)?
Weekly Report · 3d ago
Weekly Report: what happened at NRXPW last week (0216-0220)?
Weekly Report · 02/23 09:28
NRX Pharmaceuticals Files Initial Beneficial Ownership Statement for Chief Operating Officer Joseph Michael Casper
Reuters · 02/18 00:00
NRX PHARMACEUTICALS INC - FILES PROSPECTUS FOR $20 MLN COMMON STOCK - SEC FILING
Reuters · 02/17 14:21
FDA Begins Review of NRX Pharmaceuticals' New Drug Application for NRX-100
Reuters · 02/17 14:21
NRX Pharmaceuticals Advances NRX-100 Toward FDA Approval for Suicidal Depression
Reuters · 02/17 12:03
NRX PHARMACEUTICALS INC - CO TO SEEK BROADER INDICATION FOR NRX-100 FOR DEPRESSION
Reuters · 02/17 12:00
More
About NRXPW
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXPW stock methods without spending real money on the virtual paper trading platform.